A New York woman suffers severe vision loss due to a rare eye infection linked to wearing contact lenses while swimming.

Mizuho has downgraded STAAR Surgical (STAA) to neutral from outperform, citing a slowdown in sales of its Implantable ...

Fintel reports that on February 12, 2025, William Blair downgraded their outlook for STAAR Surgical (NasdaqGM:STAA) from ...

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye.

A breakthrough in bioprinting of living tissues could soon lead to 3D-printing of blood vessels and human organs, ushering in ...

STAAR Surgical (NASDAQ:STAA – Get Free Report) rose 10.4% during trading on Tuesday . The stock traded as high as $16.90 and last traded at $16.94. Approximately 1,104,525 shares were traded during ...

StockNews.com lowered shares of STAAR Surgical (NASDAQ:STAA – Free Report) from a hold rating to a sell rating in a research ...

The maker of implantable lenses posted revenue of $49 million in the period, also falling short of Street forecasts. Five analysts surveyed by Zacks expected $78 million. For the year, the company ...

LAKE FOREST, Calif., February 11, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, ...